Facilitating Access to Approved Medication

Adagrasib Tablets
Adagrasib is indicated for the treatment of adults with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC), as determined by an FDA approved test, who have received at least one prior systemic therapy.

Get Access To Adagrasib Tablets

ADAGRASIB For Injection available, genuine price cost in India US UK AE SA BR RU CN

Adagrasib Tablets

  • API: adagrasib
  • Trade Name: On Request
  • Packaging: tablets, for oral use
  • Strength: Tablets: 200 mg.
  • Indications:

What is Adagrasib Tablets used for?

Adagrasib is an inhibitor of the RAS GTPase family indicated for the treatment of adult patients with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC), as determined by an FDA approved test, who have received at least one prior systemic therapy. This indication is approved under accelerated approval based on objective response rate (ORR) and duration of response (DOR). It was approved for medical use in the United States in December 2022.

Note: (For Prescribing Information Approved Drugs, see)

  • The Food and Drug Administration (FDA), USA.
  • The European Medicines Agency (EMA).
Disclaimer

All Trademarks and Brands that appear on website belong to their respective owners does not lay and claim on them we only provide Information. We are NOT ONLINE store and We do not sell Narcotics and Sedatives. Adagrasib Tablets is a pharmaceutical drug  To access this medicine, a prescription of your treating doctor is necessary.. Following Information meant for Wholesalers, Suppliers, Exporters, Doctors, Comparator Supplies, Hospitals, Generic, Brand, Corporate Sourcing, reseller, and Pharmacies.